Peter Bruce Bitterman MD
Critical Care Medicine, Interstitial Lung Diseases, Pleural Disease
Professor, Medicine, University of Minnesota Medical School
Join to View Full Profile
University of Minnesota Medical CenterMinneapolis, MN 55455
Phone+1 612-624-0999
Dr. Bitterman is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Clinical Center at the National Institutes of HealthFellowship, Pulmonary Disease and Critical Care Medicine, 1978 - 1985
University of ChicagoResidency, Internal Medicine, 1976 - 1978
Yale School of MedicineClass of 1976
Certifications & Licensure
IL State Medical License 1977 - Present
MN State Medical License 1985 - 2021
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012, 2014-2017
- Elected Member Association of American Physicians, 2000
Publications & Presentations
PubMed
- 1 citations4E-BP inhibition ameliorates heart failure through translational upregulation of SERCA2a and modulation of mitochondrial redox signaling in cardiomyocytes.Junling Gao, Ting Lan, Xin Xu, Haipeng Guo, Siyu Wang
Redox Biology. 2026-04-01 - 2 citationsTumor suppressors RBL1 and PTEN are epigenetically silenced in IPF mesenchymal progenitor cells by a CD44/Brg1/PRMT5 regulatory complex.Libang Yang, Hong Xia, Karen Smith, Adam J Gilbertsen, Aiham H Jbeli
American Journal of Physiology. Lung Cellular and Molecular Physiology. 2024-12-01 - 4 citationsBrg1/PRMT5 nuclear complex epigenetically regulates FOXO1 in IPF mesenchymal progenitor cells.Aiham H Jbeli, Libang Yang, Hong Xia, Adam J Gilbertsen, Peter B Bitterman
American Journal of Physiology. Lung Cellular and Molecular Physiology. 2024-03-01
Grant Support
- ROLE OF FIBROTIC EXTRACELLULAR MATRIX IN GENERATING THE IPF FIBROBLASTNIH/NHLBI2014–2018
- Translational Control Of The Fibroblast Phenotype In IPFNational Heart, Lung, And Blood Institute2009–2012
- Translational Control In IPFNational Heart, Lung, And Blood Institute2008–2011
- Translational State Assay For Human SamplesNational Center For Research Resources2008–2010
- Antifibrotic Drug Discovery In Acute Lung InjuryNational Heart, Lung, And Blood Institute2004–2007
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
